MedPath

Case-control Study- Cancer Pain: Uncontrolled Pain as Depression Development Predictor in Oncologic Patients (Fentanyl)

Completed
Conditions
Cancer Pain
Interventions
Other: Visual analogue scales (EVAs)
Registration Number
NCT01402830
Lead Sponsor
Janssen-Cilag, S.A.
Brief Summary

The purpose of this study is to evaluate the relationship between cancer pain and risk of depression among cancer patients.

Detailed Description

This is a retrospective observational and case-control multicenter study. The main objective of this study is determine the degree of association between cancer pain and depression by impact assessment of adequate control of pain associated with cancer risk depression in patients attending the Oncology Unit. The assessment of pain intensity will be performed by using visual analogue scales (EVAs) and verbal descriptive scales, as an observational study, not limit or modify the use of any drug. The patients included in this study have a medical history of cancer pain and mild depression (Beck = 8). The controls are patients with history of cancer pain and mild or absent depression (Beck = 7). n/a

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
271
Inclusion Criteria
  • Patients =18 years old
  • have medical data of = 3 months
  • experience pain after cancer diagnosis and complete the Beck Depression Inventory (BDI)
  • patients who give informed written consent
  • patients with no mental or physical disorders that unable them to complete the BDI.
Exclusion Criteria
  • Patients with diagnosis of depression before cancer diagnosis
  • patients with chronic pain prior to the diagnosis of cancer, and cancer disease has not changed its course
  • patients with other previous mental disorders
  • patients who do not give their informed written consent.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
001Visual analogue scales (EVAs)Visual analogue scales (EVAs) This scale measures the pain intensity.
Primary Outcome Measures
NameTimeMethod
Beck Depression Inventory3 months
Visual scales analog (EVAs)3 months
Secondary Outcome Measures
NameTimeMethod
Number of patients with cancer pain.3 months
© Copyright 2025. All Rights Reserved by MedPath